Package 76329-3669-2

Brand: rextovy

Generic: naloxone hydrochloride
NDC Package

Package Facts

Identity

Package NDC 76329-3669-2
Digits Only 7632936692
Product NDC 76329-3669
Product ID 76329-3669_25c8bc5f-61d9-4f9e-9ce5-99c9083e2caa
Description

2 CONTAINER in 1 CONTAINER (76329-3669-2) / .25 mL in 1 CONTAINER

Marketing

Marketing Status
Marketed Since 2024-05-07
Brand rextovy
Generic naloxone hydrochloride
Sample Package No

Linked Drug Pages (1)

REXTOVY ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["NASAL"], "spl_id": "25c8bc5f-61d9-4f9e-9ce5-99c9083e2caa", "openfda": {"unii": ["F850569PQR"], "rxcui": ["2637879", "2680741"], "spl_set_id": ["fe9735db-c57e-44a8-bffb-b87a84c2a6f3"], "manufacturer_name": ["International Medication Systems, Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 CONTAINER in 1 CONTAINER (76329-3669-2)  / .25 mL in 1 CONTAINER", "package_ndc": "76329-3669-2", "marketing_start_date": "20240507"}], "brand_name": "REXTOVY", "product_id": "76329-3669_25c8bc5f-61d9-4f9e-9ce5-99c9083e2caa", "dosage_form": "SPRAY", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "76329-3669", "generic_name": "Naloxone Hydrochloride", "labeler_name": "International Medication Systems, Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "REXTOVY", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": "4 mg/.25mL"}], "application_number": "NDA208969", "marketing_category": "NDA", "marketing_start_date": "20240507", "listing_expiration_date": "20261231"}